Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that the U.S. Food and Drug Administration (FDA) has accepted ...

The damaged U.S. passport of Matthew Livelsberger, 37, an active-duty Army soldier from Colorado Springs, who police ...

In a bid to bring down the cost of insulin, California under Gov. Gavin Newsom inked a contract to produce the drug. It's ...

The Innovation Capability Centre plans to hire 750 professionals, including software engineers, data scientists, and ...

Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?

AbbVie and Simcere Zaiming have announced an option-to-license agreement for the development of an investigational drug candidate, SIM0500.

Associate Health Minister David Seymour says he is proud of the Government's commitment to increasing medicines access for New Zealanders, resulting ...

FDA Accepted Agios’ Supplemental New Drug Application for PYRUKYND® (mitapivat) in Adult Patients with Non-Transfusion-Dependent and ...

Hinge Bio, Inc., a privately-held biotechnology company, today announced the close of a Series A' financing led by Point72. Joining Point72 are Ridgeback Capital, InVivium Capital, and Lightswitch ...

We recently compiled a list of the Jim Cramer’s Lightning Round: 7 Stocks Under the Spotlight. In this article, we are going to take a look at where The Kraft Heinz Company (NASDAQ:KHC) stands against ...

AbbVie and Simcere Zaiming, a subsidiary of Simcere Pharmaceutical Group Ltd., entered an option to license agreement to ...

The 21st century pharmaceutical and ... improvements in standards of living and technological optimism that characterised the 40s to the early 70s, as well as the science-boosting competition ...